TSE:OGI Organigram (OGI) Stock Forecast, Price & News C$1.92 -0.10 (-4.95%) (As of 09/26/2023 ET) Add Compare Share Share Today's RangeC$1.92▼C$2.0550-Day RangeC$1.77▼C$2.5352-Week RangeC$1.73▼C$6.84Volume138,642 shsAverage Volume119,010 shsMarket CapitalizationC$154.56 millionP/E RatioN/ADividend YieldN/APrice TargetC$3.36 ProfileProfileAnalyst RatingsChartCompetitorsEarningsHeadlinesOptions ChainSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsHeadlinesOptions ChainSocial Media About Organigram (TSE:OGI) StockOrganigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was incorporated in 2010 and is headquartered in Toronto, Canada.Read More OGI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OGI Stock News HeadlinesSeptember 25, 2023 | theglobeandmail.comLegal cannabis labels inflate THC potency contained in products, executives saySeptember 17, 2023 | americanbankingnews.comOrganigram (TSE:OGI) Reaches New 52-Week High at $2.68September 26, 2023 | Micro-Cap Stock Trader (Ad)Unlock the treasure on Mount Olympus with this little-known mining stock.Investor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsSeptember 15, 2023 | finance.yahoo.comDigicann Ventures Announces Receipt of Last Portion of Final Earnout Milestone PaymentSeptember 1, 2023 | finance.yahoo.comOrganigram Announces Resignation of Board MemberAugust 28, 2023 | finance.yahoo.comOrganigram Launches First Range of THCV Products Derived from Moncton-Grown Whole FlowerJuly 14, 2023 | seekingalpha.comOrganigram Holdings reports Q3 results; initiates Q4 soft guidanceJuly 13, 2023 | finance.yahoo.comOrganigram Reports Third Quarter Fiscal 2023 ResultsSeptember 26, 2023 | Micro-Cap Stock Trader (Ad)U.S. drive to onshore battery supply chains could create big winners in lithiumInvestor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsJuly 12, 2023 | msn.comEarnings Outlook For OrganiGram HoldingsJuly 5, 2023 | finance.yahoo.comWill Organigram Holdings (TSE:OGI) Spend Its Cash Wisely?June 24, 2023 | fool.comOrganigram (TSX: OGI)June 8, 2023 | finance.yahoo.comThe Price Is Right For Organigram Holdings Inc. (TSE:OGI)May 25, 2023 | uk.finance.yahoo.comOGI - Organigram Holdings Inc.May 23, 2023 | msn.comOrganigram To Enter German Cannabis Market Via Sanity GroupMay 23, 2023 | finance.yahoo.comAgra Ventures Announces Receipt of Earnout Milestone PaymentMay 23, 2023 | finance.yahoo.comOrganigram to Enter German Market Supplying Sanity GroupMay 15, 2023 | msn.comOrganigram Is The Best Cannabis StockMay 10, 2023 | msn.comOrganigram Is Almost ThereApril 22, 2023 | theglobeandmail.comClosing Bell: Organigram Holdings Inc flat on Friday (OGI)April 19, 2023 | theglobeandmail.comClosing Bell: Organigram Holdings Inc up on Wednesday (OGI)April 14, 2023 | theglobeandmail.comClosing Bell: Organigram Holdings Inc down on Friday (OGI)April 12, 2023 | theglobeandmail.comClosing Bell: Organigram Holdings Inc down on Wednesday (OGI)April 12, 2023 | finance.yahoo.comWhy Organigram Holdings Stock Is Plummeting TodayApril 12, 2023 | msn.comWhy Organigram Shares Are Crashing TodayApril 12, 2023 | markets.businessinsider.comHaywood Remains a Hold on OrganiGram Holdings (OGI)April 12, 2023 | msn.comEarnings Preview For OrganiGram HoldingsSee More Headlines Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address OGI Company Calendar Last Earnings7/13/2023Today9/26/2023Next Earnings (Estimated)11/27/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Drug Manufacturers—Specialty & Generic Sub-IndustryCannabis SectorMedical Current SymbolTSE:OGI CUSIPN/A CIKN/A Webwww.organigram.ca Phone844-644-4726FaxN/AEmployees923Year FoundedN/APrice Target and Rating Average Stock Price ForecastC$3.36 High Stock Price ForecastC$6.50 Low Stock Price ForecastC$1.50 Forecasted Upside/Downside+69.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)C($2.28) Trailing P/E RatioN/A Forward P/E Ratio28.38 P/E Growth0.42Net IncomeC$-221,750,000.00 Net Margins-137.67% Pretax MarginN/A Return on Equity-54.53% Return on Assets-5.56% Debt Debt-to-Equity Ratio0.06 Current Ratio4.54 Quick Ratio2.62 Sales & Book Value Annual SalesC$161.08 million Price / Sales0.99 Cash FlowC$0.51 per share Price / Cash Flow3.85 Book ValueC$3.75 per share Price / Book0.53Miscellaneous Outstanding Shares80,500,000Free FloatN/AMarket CapC$159.39 million OptionableOptionable Beta1.37 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMs. Beena G. Goldenberg (Age 60)CEO & Director Comp: $585.53kMr. Derrick W. West CPA (Age 56)CPA, (CA), Chief Financial Officer Comp: $403.86kMs. Helen Martin (Age 45)Chief Legal Officer & Corp. Sec. Comp: $390.53kMr. Timothy EmbergChief Commercial OfficerMr. Paolo De Luca C.A. (Age 50)C.F.A, Chief Strategy Officer Comp: $395.52kMs. Nathalie BattenVP of OperationsMr. Geoff RiggsChief Information OfficerMax SchwartzDirector of Investor RelationsMs. Megan Amber McCraeSr. VP of Marketing & CommunicationsMs. Katrina May McFaddenChief People OfficerMore ExecutivesKey CompetitorsHLS TherapeuticsTSE:HLSCipher PharmaceuticalsTSE:CPHBioSyentCVE:RXCharlotte's WebTSE:CWEBCardiol TherapeuticsTSE:CRDLView All Competitors OGI Stock - Frequently Asked Questions Should I buy or sell Organigram stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OGI shares. View OGI analyst ratings or view top-rated stocks. What is Organigram's stock price forecast for 2023? 1 brokers have issued 12-month target prices for Organigram's stock. Their OGI share price forecasts range from C$1.50 to C$6.50. On average, they anticipate the company's share price to reach C$3.36 in the next twelve months. This suggests a possible upside of 69.6% from the stock's current price. View analysts price targets for OGI or view top-rated stocks among Wall Street analysts. How have OGI shares performed in 2023? Organigram's stock was trading at C$1.10 at the beginning of 2023. Since then, OGI stock has increased by 80.0% and is now trading at C$1.98. View the best growth stocks for 2023 here. When is Organigram's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 27th 2023. View our OGI earnings forecast. How were Organigram's earnings last quarter? Organigram Holdings Inc. (TSE:OGI) announced its earnings results on Thursday, July, 13th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.12. The firm earned $32.79 million during the quarter, compared to the consensus estimate of $42.89 million. Organigram had a negative net margin of 137.67% and a negative trailing twelve-month return on equity of 54.53%. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), Green Organic Dutchman (TGOD), Charlotte's Web (CWBHF) and CannTrust (CTST). What is Organigram's stock symbol? Organigram trades on the Toronto Stock Exchange (TSX) under the ticker symbol "OGI." How do I buy shares of Organigram? Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Organigram's stock price today? One share of OGI stock can currently be purchased for approximately C$1.98. How much money does Organigram make? Organigram (TSE:OGI) has a market capitalization of C$159.39 million and generates C$161.08 million in revenue each year. The company earns C$-221,750,000.00 in net income (profit) each year or C($2.28) on an earnings per share basis. How many employees does Organigram have? The company employs 923 workers across the globe. How can I contact Organigram? Organigram's mailing address is 333 Bay Street, Suite 1250, Toronto, ON M5H 2R2, Canada, . The official website for the company is www.organigram.ca. The company can be reached via phone at 844-644-4726. This page (TSE:OGI) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.